Lineage Cell Therapeutics
LCTX
#8848
Rank
โ‚น9.23 B
Marketcap
โ‚น40.43
Share price
14.59%
Change (1 day)
-65.60%
Change (1 year)

Revenue for Lineage Cell Therapeutics (LCTX)

Revenue in 2024 (TTM): โ‚น0.80 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น0.81 Billion. an increase over the revenue in the year 2023 that were of โ‚น0.74 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lineage Cell Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น0.81 B9.43%
2023 โ‚น0.74 B-38.8%
2022 โ‚น1.21 B319.57%
2021 โ‚น0.28 B412.95%
2020 โ‚น56.53 M-46.36%
2019 โ‚น0.10 B6.45%
2018 โ‚น99.01 M-13.47%
2017 โ‚น0.11 B-24.83%
2016 โ‚น0.15 B-9.54%
2015 โ‚น0.16 B36.49%
2014 โ‚น0.12 B-30.25%
2013 โ‚น0.17 B1749.62%
2012 โ‚น9.55 M-95.89%
2011 โ‚น0.23 B40.98%
2010 โ‚น0.16 B84.73%
2009 โ‚น89.32 M23.59%
2008 โ‚น72.27 M76.06%
2007 โ‚น41.05 M-20.23%
2006 โ‚น51.46 M26.63%
2005 โ‚น40.64 M36.33%
2004 โ‚น29.81 M17.68%
2003 โ‚น25.33 M36.5%
2002 โ‚น18.55 M153.19%
2001 โ‚น7.33 M139.38%
2000 โ‚น3.06 M-93.21%
1999 โ‚น45.1 M
1997 โ‚น23.57 M118.64%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA